Evaluating the Use of an App in Pleural Disease: Algorithm-supported Clinical Decision Making Versus Usual Care
NCT07625176 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 828
Last updated 2026-06-04
Summary
Pleural disease is a group of conditions that affect the membrane around the lungs. These conditions-fluid around the lungs, infections, cancer, and collapsed lung-are common and can cause serious illness. They often lead to long hospital stays, emergency admissions, and reduced quality of life. In Denmark and worldwide, the number of patients with pleural disease is rising, and the treatment is costly for the healthcare system.
How long patients stay in the hospital depends on the type of pleural disease. Some stay less than a week, while others remain for several weeks, especially if complications occur. Research shows that early diagnosis and treatment based on clinical guidelines can shorten hospital stays and improve outcomes.
In the UK, many hospitals have created dedicated pleural clinics run by specialists. These clinics help ensure that patients receive fast, consistent, and evidence based care, and they have reduced the number of days patients spend in hospital. In Denmark, however, such clinics are rare. A recent national survey showed that many Danish hospitals do not follow current pleural disease guidelines, and many lack clear pathways for diagnosing and treating these patients. As a result, patients may receive suboptimal care.
This project aims to close that gap. The goal is to develop an easy to use, guideline based decision tool that supports doctors in emergency, medical, and surgical departments. The tool will guide clinicians from the moment a patient arrives until discharge, helping them choose the right tests and treatments at the right time. By making expert knowledge accessible to non specialists, the project hopes to improve patient care, reduce complications, and shorten hospital stays.
Ultimately, the project seeks to ensure that all patients with pleural disease in Denmark receive fast, safe, and evidence based treatment-no matter where they are admitted.
Conditions
- Pleural Diseases
- Pneumothorax Spontaneous Primary
- Pneumothorax Spontaneous Secondary
- Pleural Effusion
- Pleural Infection
Interventions
- BEHAVIORAL
-
Clinical decision-making support tool
Care for patients with spontaneous pneumothorax, pleural effusion or pleural infection when supported by a clinical decision-support tool, in the form of a smartphone app.
- OTHER
-
Usual care
Care supported by a clinical decision-support tool delivered via a smartphone app.
Sponsors & Collaborators
-
Zealand University Hospital
lead OTHER
Principal Investigators
-
Casper Jensen, MD · Lungemedicinsk Forskningsenhed (PLUZ), Institut for Regional Sundhedsforskning, Syddansk Universitet
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2026-10-15
- Completion
- 2026-10-15
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis
NCT04130451 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Investigation Into the Automated Drainage of Recurrent Effusions From the Pleural Space in Thoracic Malignancy.
NCT01952327 ·Status: TERMINATED ·Phase: NA
-
Comparison of Exsufflation Versus Drainage in Primary Spontaneous Pneumothorax
NCT01008228 ·Status: COMPLETED ·Phase: NA
-
Absorbable Mesh Pleurodesis in Thoracoscopic Treatment of Spontaneous Pneumothorax
NCT01848860 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Fibrinolytic Therapy Versus Medical Thoracoscopy
NCT03213834 ·Status: COMPLETED ·Phase: PHASE4
-
Early Intrapleural TPA Instillation Versus Late
NCT03167281 ·Status: WITHDRAWN ·Phase: PHASE4
-
ABPT in Secondary Pneumothorax With Persistent Airleak Study
NCT04132687 ·Status: UNKNOWN ·Phase: NA
-
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
NCT06411431 ·Status: RECRUITING ·Phase: NA
-
Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema
NCT00234208 ·Status: TERMINATED ·Phase: PHASE3
-
Pleurectomy Versus Pleural Abrasion in Patients With Spontaneous Pneumothorax
NCT05407974 ·Status: UNKNOWN ·Phase: NA
-
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
NCT02973139 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure
NCT05465083 ·Status: COMPLETED ·Phase: NA
-
Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
NCT03583931 ·Status: COMPLETED ·Phase: NA
-
PleuraSeal Post Market Study (Europe)
NCT00704171 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Primary Spontaneous Pneumothorax (PSP) Treatment Techniques in VATS
NCT01463553 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life
NCT06471608 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage
NCT00556335 ·Status: COMPLETED ·Phase: NA
-
Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure
NCT02837601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
NCT03231033 ·Status: COMPLETED ·Phase: PHASE1
-
The ACES Study for Aseptic Pleural Effusion
NCT06210685 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax
NCT00418392 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation
NCT02235610 ·Status: RECRUITING ·Phase: NA
-
PleuraSeal Pivotal Study (US)
NCT00748124 ·Status: TERMINATED ·Phase: PHASE3
-
Extracorporeal Lung Assist Device in Acute Lung Impairment
NCT02550600 ·Status: UNKNOWN ·Phase: NA
-
EDIT Management Feasibility Trial
NCT03319186 ·Status: UNKNOWN ·Phase: NA